Familial and phenotypic associations of the aldosterone renin ratio

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 11, 2009, Pages 4324-4333

  Alvarez Madrazo, Samantha ^a   Padmanabhan, Sandosh ^a   Mayosi, Bongani M ^b,c   Watkins, Hugh ^c   Avery, Peter ^d   Wallace, A Michael ^e   Fraser, Robert ^a   Davies, Eleanor ^a   Keavney, Bernard ^d   Connell, John M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MARKER; POTASSIUM; RENIN; STEROID 11BETA MONOOXYGENASE;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BODY MASS; CAUCASIAN; CHEMOLUMINESCENCE; ENVIRONMENTAL FACTOR; FAMILY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEREDITY; HERITABILITY; HOMEOSTASIS; HUMAN; HYPERTENSION; IMMUNOASSAY; INTRON; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PLASMA RENIN ACTIVITY; POPULATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 70449122766     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1406     Document Type: Article

References (35)

1. Montori VM, Young Jr WF 2002 Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am 31:619-632, xi
2. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young Jr WF 2004 Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89:1045-1050 (Pubitemid 38368386)
3. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:3266-3281
4. Padfield PL 2003 Prevalence and role of a raised aldosterone to renin ratio in the diagnosis of primary aldosteronism: a debate on the scientific logic of the use of the ratio in practice. Clin Endocrinol (Oxf) 59:422-426
5. Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, Papadopoulos N, Vogiatzis K, Zamboulis C 2008 Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 371:1921-1926 (Pubitemid 351778191)
6. Gordon RD, Ziesak MD, Tunny TJ, Stowasser M, Klemm SA 1993 Evidence that primary aldosteronism may not be uncommon: 12% incidence among hypertensive drug trial volunteers. Clin Exp Pharmacol Physiol 20:296-298 (Pubitemid 23140199)
7. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM 1999 Potentially high prevalence of primary aldosteronism in a primarycare population. Lancet 353:40 (Pubitemid 29037708)
8. Stowasser M, Gordon RD 2004 Primary aldosteronism-careful investigation is essential and rewarding. Mol Cell Endocrinol 217:33-39 (Pubitemid 38596626)
9. Padfield PL 2002 Primary aldosteronism, a common entity? The myth persists. J Hum Hypertens 16:159-162
10. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F 2006 A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293-2300 (Pubitemid 44873058)
11. Connell JM, MacKenzie SM, Freel EM, Fraser R, Davies E 2008 A lifetime of aldosterone excess: Long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev 29:133-154
12. Connell JM, Davies E 2005 The new biology of aldosterone. J Endocrinol 186:1-20
13. Alderman MH, Cohen HW, Sealey JE, Laragh JH 2004 Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients. Am J Hypertens 17:1-7
14. Goodfriend TL, Calhoun DA 2004 Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 43:518-524 (Pubitemid 38282420)
15. Tiu SC, Choi CH, Shek CC, Ng YW, Chan FK, Ng CM, Kong AP 2005 The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 90:72-78
16. James GD, Sealey JE, Müller F, Alderman M, Madhavan S, Laragh JH 1986 Renin Relationship to Sex, Race and Age in A Normotensive Population. J Hypertens Suppl 4:S387-S389 (Pubitemid 17054558)
17. Schunkert H, Danser AH, Hense HW, Derkx FH, Kürzinger S, Riegger GA 1997 Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 95:39-45 (Pubitemid 27029940)
18. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ, Levy D 2004 Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 351:33-41 (Pubitemid 38857245)
19. Newton-Cheh C, Guo CY, Gona P, Larson MG, Benjamin EJ, Wang TJ, Kathiresan S, O'Donnell CJ, Musone SL, Camargo AL, Drake JA, Levy D, Hirschhorn JN, Vasan RS 2007 Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension 49:846-856 (Pubitemid 351664212)
20. Parikh NI, Gona P, Larson MG, Wang TJ, Newton-Cheh C, Levy D, Benjamin EJ, Kannel WB, Vasan RS 2007 Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study. Eur Heart J 28:2644-2652 (Pubitemid 350071528)
21. Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, Anderson NH, Fraser R, Connell JMC 1999 Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 33:703-707 (Pubitemid 29091652)
22. Baker M, Gaukrodger N, Mayosi BM, Imrie H, Farrall M, Watkins H, Connell JM, Avery PJ, Keavney B 2005 Association between common polymorphisms of the proopiomelanocortin gene and body fat distribution - a family study. Diabetes 54:2492-2496 (Pubitemid 41134281)
23. Gaukrodger N, Mayosi BM, Imrie H, Avery P, Baker M, Connell JM, Watkins H, Farrall M, Keavney B 2005 A rare variant of the leptin gene has large effects on blood pressure and carotid intima-medial thickness: a study of 1428 individuals in 248 families. J Med Genet 42:474-478 (Pubitemid 40847234)
24. Keavney B, Mayosi B, Gaukrodger N, Imrie H, Baker M, Fraser R, Ingram M, Watkins H, Farrall M, Davies E, Connell J 2005 Genetic variation at the locus encompassing 11-βhydroxylase and aldosterone synthase accounts for heritability in cortisol precursor (11-deoxycortisol) urinary metabolite excretion. J Clin Endocrinol Metab 90:1072-1077 (Pubitemid 40279236)
25. Barr M, MacKenzie SM, Friel EC, Holloway CD, Wilkinson DM, Brain NJ, Ingram MC, Fraser R, Brown M, Samani NJ, Caulfield M, Munroe PB, Farrall M, Webster J, Clayton D, Dominiczak AF, Connell JM, Davies E 2007 Polymorphic variation in the 11 β-hydroxylase gene associates with reduced 11-hydroxylase efficiency. Hypertension 49:113-119 (Pubitemid 46360349)
26. Imrie H, Freel M, Mayosi BM, Davies E, Fraser R, Ingram M, Cordell HJ, Farrall M, Avery PJ, Watkins H, Keavney B, Connell JM 2006 Association between aldosterone production and variation in the 11 β-hydroxylase (CYP11B1) gene. J Clin Endocrinol Metab 91:5051-5056 (Pubitemid 44917349)
27. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, Najjar S, Zhao JH, Heath SC, Eyheramendy S, Papadakis K, Voight BF, Scott LJ, Zhang F, Farrall M, Tanaka T, Wallace C, Chambers JC, Khaw KT, Nilsson P, van der Harst P, Polidoro S, Grobbee DE, Onland-Moret NC, Bots ML, Wain LV, Elliott KS, Teumer A, Luan J, Lucas G, Kuusisto J, Burton PR, Hadley D, McArdle WL, Brown M, Dominiczak A, Newhouse SJ, et al. 2009 Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 41:666-676
28. Tobin MD, Sheehan NA, Scurrah KJ, Burton PR 2005 Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 24:2911-2935
29. Abecasis GR, Cherny SS, Cookson WO, Cardon LR 2002 Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30:97-101
30. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC 2007 PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575 (Pubitemid 47330214)
31. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC 1994 High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21:315-318 (Pubitemid 24201225)
32. Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, Veglio F 2002 Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 40:897-902 (Pubitemid 35434913)
33. Sealey JE, Itskovitzeldor J, Rubattu S, James GD, August P, Thaler I, Levron J, Laragh JH 1994 Estradiol-related and progesterone-related increases in the renin-aldosterone system - studies during ovarian stimulation and early pregnancy. J Clin Endocrinol Metab 79:258-264 (Pubitemid 24221193)
34. Paillard F, Chansel D, Brand E, Benetos A, Thomas F, Czekalski S, Ardaillou R, Soubrier F 1999 Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 34:423-429 (Pubitemid 29426758)
35. Connell JM, Fraser R, MacKenzie S, Davies E 2003 Is altered adrenal steroid synthesis a key intermediate phenotype in hypertension? Hypertension 41:993-999